Conversely, samples from patients with relapsed AML with high FLT3mut+ allelic burden were more sensitive to FLT3 inhibition compared to samples obtained at diagnosis with lower FLT3mut+ AR (21). Here, FLT3 is linked to acute myeloid leukemia.